Get the app!
Back to Trades

Outlook Therapeutics, Inc.

OTLKCIK: 0001649989

Follow OTLK

Track Outlook Therapeutics, Inc. insider trades on your dashboard. Email alerts with a subscription.

Outlook Therapeutics, Inc. (OTLK) has recorded 15 insider filings from 10 unique insiders, totaling $46.1M in trading activity (net buying). Insiders have purchased $5.3M and sold $0, reflecting a net buying posture that may signal internal confidence in the company's near-term prospects. The most active insider by volume is Sukhtian Ghiath M.. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.

Total Volume
$46.1M
Purchases
$5.3M
Sales
$0
Unique Insiders
10

Recent Insider Trades

15 loaded
Jun 3OTLK
Outlook Therapeutics, Inc.
Haddadin Yezan MuntherDirectorBuy$24.1K
Jun 1OTLK
Outlook Therapeutics, Inc.
Sukhtian Ghiath M.InsiderBuy$5.0M
May 27OTLK
Outlook Therapeutics, Inc.
Sukhtian Faisal GhiathDirectorBuy$50.0K
May 27OTLK
Outlook Therapeutics, Inc.
Haddadin Yezan MuntherDirectorBuy$15.0K
May 27OTLK
Outlook Therapeutics, Inc.
THURMAN RANDY HDirectorBuy$2.1K
May 27OTLK
Outlook Therapeutics, Inc.
HILZINGER KURT JDirectorBuy$176.5K
Oct 3OTLK
Outlook Therapeutics, Inc.
Auffarth GerdDirectorOther$0
Oct 3OTLK
Outlook Therapeutics, Inc.
Gangolli Julian SDirectorOther$0
Oct 3OTLK
Outlook Therapeutics, Inc.
HILZINGER KURT JDirectorOther$0
Oct 3OTLK
Outlook Therapeutics, Inc.
Huang AndongDirectorOther$0
Oct 3OTLK
Outlook Therapeutics, Inc.
Sukhtian Faisal GhiathDirectorOther$0
Oct 3OTLK
Outlook Therapeutics, Inc.
Haddadin Yezan MuntherDirectorOther$0
Oct 3OTLK
Outlook Therapeutics, Inc.
Haller Julia ADirectorOther$0
Oct 3OTLK
Outlook Therapeutics, Inc.
THURMAN RANDY HDirectorOther$0
Jul 9OTLK
Outlook Therapeutics, Inc.
Jahr Robert CharlesInsiderOther$0

15 filings